New rabies shot shows promise in preventing deadly infection after bites

NCT ID NCT03961555

Completed Prevention Sponsor: Synermore Biologics Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tested a new medicine called SYN023 to prevent rabies in people who were bitten or scratched by animals like dogs or bats. About 448 adults with different levels of rabies risk received either SYN023 or the standard rabies immune globulin, along with the rabies vaccine. The goal was to see if SYN023 works as well as the current treatment to stop rabies from developing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RABIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rabies prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RABIES

Contacts and locations

Locations

Asian Hospital and Medical Center

Muntinlupa, National Capital Region, 1780, Philippines
Baguio General Hospital and Medical Center

Baguio City, Benguet, 2600, Philippines
Center of Excellence in Drug Research, Evaluation and Studies, Inc.

Muntinlupa, National Capital Region, 1781, Philippines
Clinical Research Solutions PC -Milan

Milan, Tennessee, 38358, United States
De La Salle Health Sciences Institute Independent Ethics Committee

Cavite City, Calabarzon, 4114, Philippines
Far Eastern University Hospital Nicanor Reyes Medical Foundation

Quezon City, National Capital Region, 1118, Philippines
Manila Doctors Hospital Institutional Review Board

Manila, National Capital Region, 1000, Philippines
Mary Johnston Hospital

Manila, Philippines
Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States
Research Institute For Tropical Medicine

Muntinlupa, National Capital Region, 1781, Philippines
Southern Philippines Medical Center

Davao City, Davao (Region XI), 8000, Philippines
University of Florida

Gainesville, Florida, 32610, United States
University of Iowa

Iowa City, Iowa, 52242, United States
University of Virginia

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.